Baillie Gifford & CO Edwards Lifesciences Corp Transaction History

Baillie Gifford & CO

$126 Billion
Q2 2024

A detailed history of Baillie Gifford & CO transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Baillie Gifford & CO holds 352,303 shares of EW stock, worth $23.1 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

352,303

Previous 396,553 11.16%

Holding current value

$23.1 Million

Previous $37.9 Million 14.12%

% of portfolio

0.03%

Previous 0.03%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 25, 2024	SELL	$84.3 - $94.31 $3.73 Million - $4.17 Million	-44,250 Reduced 11.16%	352,303 $32.5 Million
Q1 2024 May 01, 2024	SELL	$72.54 - $95.56 $537,158 - $707,621	-7,405 Reduced 1.83%	396,553 $37.9 Million
Q4 2023 Jan 26, 2024	SELL	$61.71 - $77.76 $2.25 Million - $2.83 Million	-36,443 Reduced 8.27%	403,958 $30.8 Million
Q3 2023 Nov 13, 2023	SELL	$69.28 - $93.38 $1.64 Million - $2.21 Million	-23,639 Reduced 5.09%	440,401 $30.5 Million
Q2 2023 Jul 28, 2023	SELL	$81.41 - $94.33 $280,376 - $324,872	-3,444 Reduced 0.74%	464,040 $43.8 Million
Q1 2023 May 03, 2023	BUY	$74.26 - $84.51 $2.38 Million - $2.7 Million	31,993 Added 7.35%	467,484 $38.7 Million
Q4 2022 Jan 24, 2023	BUY	$68.3 - $87.44 $228,463 - $292,486	3,345 Added 0.77%	435,491 $32.5 Million
Q3 2022 Oct 27, 2022	BUY	$82.37 - $107.29 $981,932 - $1.28 Million	11,921 Added 2.84%	432,146 $35.7 Million
Q2 2022 Aug 08, 2022	SELL	$86.5 - $128.27 $432,500 - $641,350	-5,000 Reduced 1.18%	420,225 $40 Million
Q1 2022 May 05, 2022	SELL	$101.96 - $128.34 $760,927 - $957,801	-7,463 Reduced 1.72%	425,225 $50.1 Million
Q4 2021 Jan 20, 2022	BUY	$106.37 - $130.68 $1.19 Million - $1.46 Million	11,143 Added 2.64%	432,688 $56.1 Million
Q3 2021 Oct 19, 2021	BUY	$102.91 - $122.75 $1.83 Million - $2.18 Million	17,758 Added 4.4%	421,545 $47.7 Million
Q2 2021 Aug 02, 2021	SELL	$83.84 - $104.76 $98,092 - $122,569	-1,170 Reduced 0.29%	403,787 $41.8 Million
Q1 2021 May 06, 2021	BUY	$78.68 - $90.67 $9.81 Million - $11.3 Million	124,646 Added 44.47%	404,957 $33.9 Million
Q4 2020 Feb 10, 2021	BUY	$71.69 - $91.23 $1.92 Million - $2.45 Million	26,830 Added 10.58%	280,311 $25.6 Million
Q3 2020 Nov 12, 2020	BUY	$67.19 - $87.44 $3.95 Million - $5.14 Million	58,738 Added 30.16%	253,481 $20.2 Million
Q2 2020 Aug 12, 2020	BUY	$57.54 - $76.95 $11.1 Million - $14.9 Million	193,606 Added 17027.79%	194,743 $13.5 Million
Q1 2020 May 08, 2020	SELL	$52.41 - $81.0 $6,236 - $9,639	-119 Reduced 9.47%	1,137 $214,000
Q3 2019 Nov 07, 2019	SELL	$61.55 - $75.43 $4,370 - $5,355	-71 Reduced 5.35%	1,256 $276,000
Q4 2018 Feb 14, 2019	BUY	$46.41 - $56.94 $61,586 - $75,559	1,327 New	1,327 $203,000

Others Institutions Holding EW

# of Institutions

1,417

Shares Held

469M

Call Options Held

2.44M

Put Options Held

2.65M

View Full List

About Edwards Lifesciences Corp

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $40.5B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

More about EW

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Baillie Gifford & CO, based on Form 13F filings with the SEC.

News

Stay updated on Baillie Gifford & CO with notifications on news.

Account

Baillie Gifford & CO Edwards Lifesciences Corp Transaction History